post-stroke spasticity
Neurology · 2019–2019
2decisions
2medicines
0carried consumer input
0individual submissions
No submission for this condition has carried consumer input, including the 2 made since the comments facility came into use.
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| botulinum toxin type A Moderate to severe lower limb focal spasticity following a stroke or other acute central nervous system injury (including traumatic brain injury and spinal… | Mar 2019 | Recommended with restriction | none received |
| incobotulinumtoxin A Moderate to severe spasticity of the upper limb following an acute event (including stroke, traumatic brain injury, spinal cord injury, infection, or hypoxia). | Nov 2019 | Recommended with restriction | none received |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 0 of 2 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.